Invivyd (IVVD) Shares Outstanding (Diluted) (2021 - 2026)
Powered by 
Analysis
Invivyd (IVVD) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 544.00 Mn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 1.24 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 255.20 Mn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 106.00 Mn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 66.03 Mn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 398.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 138.28 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 148.70 Mn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Invivyd | 244.65 Mn | 84.57 Mn | 13.01 Mn | 320.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 320.44 Mn |
| Dec 31, 2025 | 172.21 Mn |
| Sep 30, 2025 | 170.17 Mn |
| Jun 30, 2025 | 120.02 Mn |
| Mar 31, 2025 | 119.88 Mn |
| Dec 31, 2024 | 118.56 Mn |
| Sep 30, 2024 | 119.50 Mn |
| Jun 30, 2024 | 119.36 Mn |
| Mar 31, 2024 | 115.62 Mn |
| Dec 31, 2023 | 109.53 Mn |
| Sep 30, 2023 | 109.75 Mn |
| Jun 30, 2023 | 109.45 Mn |
| Mar 31, 2023 | 108.79 Mn |
| Dec 31, 2022 | 108.27 Mn |
| Sep 30, 2022 | 108.42 Mn |
| Jun 30, 2022 | 108.17 Mn |
| Mar 31, 2022 | 107.87 Mn |
| Dec 31, 2021 | 42.62 Mn |
| Sep 30, 2021 | 61.30 Mn |
| Jun 30, 2021 | 249,769.00 |